Home›Methodology

How we score weight loss programs

Five dimensions, ten points each, weighted equally. Same framework applied to every program in the chart. Published here so you can repeat it yourself.

Editor John Samaras

How we choose which programs to include

The bar is simple: a US patient has to be able to actually buy a GLP-1 from the program on cash-pay today. That covers three kinds of seller: the large telehealth platforms (Hims, Ro, Noom, LifeMD and the like), the compounding pharmacies that sell semaglutide and tirzepatide directly, and the manufacturer programs (NovoCare, LillyDirect). About 31 right now, and the list grows as new programs launch.

What we leave out: no-prescription grey-market sellers, anything that will not ship to the US, and programs with no discoverable price at all. When a program shows its price only after you sign up, we flag that on its row rather than drop it, since the disappearing price is part of the story.

We do not cap the list or rotate programs off to keep it short. Every program that meets the bar stays, on its own page, scored the same way. A program leaves only when it shuts down or stops selling.

Missing one, or see a price that looks wrong? Tell us at hello@glpchart.com and we will check it.

Scoring framework

Each program receives a score across five dimensions. Each dimension is weighted equally. Overall score is the simple average.

1Pricing transparency (1-10)

  • Are all costs published before sign-up?
  • Are introductory prices clearly distinguished from ongoing prices?
  • Are mandatory add-ons (lab work, shipping, consult fees) shown upfront?
  • Is the dose-by-dose cost progression visible?

2Cancellation terms (1-10)

  • What is the minimum commitment, if any?
  • How does cancellation work? Is it self-serve or does it require a phone call?
  • Are there cancellation fees or pro-rated charges?
  • Are members locked into refilling unused supply?

3Onboarding experience (1-10)

  • How long from sign-up to first prescription?
  • Is the medical consultation synchronous or asynchronous?
  • What information must the member provide?
  • Are required follow-ups clearly scheduled?

4Medication options (1-10)

  • What classes of weight loss medication does the program offer?
  • Is the medication an approved branded product, an approved generic or compounded?
  • How is dosing managed and adjusted?
  • Is the program transparent about medication sourcing?

5Member reviews (1-10)

This pillar is the program's public Trustpilot rating, mapped straight to our 0-10 scale (a 4.5 out of 5 becomes a 9.0). It measures member satisfaction with the program, not clinical outcomes, so we renamed it from "member-reported outcomes" to be accurate about what it captures.

  • What is the program's current TrustScore on Trustpilot, across how many reviews?
  • The score on every row links to that program's Trustpilot page so you can read the reviews yourself.
  • Some programs have no Trustpilot profile. We label those "no Trustpilot profile" rather than invent a number, and the pillar leans on other public member feedback instead.
  • For big-box retailers we score the service-specific Trustpilot profile where one exists (for example Amazon Pharmacy), not the parent store's general retail rating.

How we collect data

Pricing and policies are checked every Monday against each program's published pricing pages. When a program's site blocks automated access, we confirm the published figure through a web search of the program's own materials. We do not create accounts, purchase medication or make payments to gather pricing. The Member reviews pillar is each program's public Trustpilot rating, linked from its row so you can verify it. Where a program has no Trustpilot profile we label it as such instead of inventing a score. We do not pay or solicit reviews.

What we don't do

  • We do not let programs approve content before publication.
  • We do not change rankings in exchange for payment, sponsorship or marketing partnerships.
  • We do not remove unfavorable information at a program's request unless it is factually incorrect.
  • We do not present compounded medications as FDA-approved or vice versa. The regulatory status of every option is labeled clearly.

When a program has an unresolved FDA warning letter or court action, we say so on its page and its chart row. Listings and rankings never change for commercial reasons, and disclosures never disappear while the action is unresolved.

Update cadence

Prices are checked against each program's published pricing every Monday. Full program re-scores happen quarterly or whenever a program announces a material change to pricing, lock-in terms or medication availability.

Get in touch

Questions, errors or methodology suggestions: hello@glpchart.com

Methodology last reviewed July 13. Prices are checked every Monday; the scoring criteria are reviewed quarterly.

See monthly rankings for the current program order and best by use case for curated picks. Our editorial on who writes GLP-1 rankings explains why a published methodology matters and how to verify independence claims on comparison sites.

John Samaras, editor of GLP Chart
John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site · LinkedIn · Contact
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.